Alpha Dna Investment Management LLC Denali Therapeutics Inc. Transaction History

Alpha Dna Investment Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 10, 2021	SELL	$50.3 - $78.44 $3,973 - $6,196	-79 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$53.8 - $81.53 $914 - $1,386	17 Added 27.42%	79 $4,000
Q4 2020 Mar 24, 2021	BUY	$36.89 - $93.56 $922 - $2,339	25 Added 67.57%	62 $5,000
Q4 2020 Feb 16, 2021	BUY	$36.89 - $93.56 $1,364 - $3,461	37 New	37 $3,000

226

119M

60.6K

48.4K

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $3.13B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

Get notified when there are updates to the investment portfolio of Alpha Dna Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Dna Investment Management LLC with notifications on news.